The present results indicate that Cdx2 overexpression, as detected by immunohistochemistry, were significantly associated with sex, clinical stage, differentiation, vascular invasion and lymph node metastasis, as well as 5-year survival rate. The gene discussed is CDX2; the disease is metastatic malignant neoplasm in the lymph nodes.